Literature DB >> 26190705

Proton pump inhibitors: use, misuse and concerns about long-term therapy.

T P Rakesh1.   

Abstract

Proton pump inhibitors (PPIs) are widely used in acid-related disorders of the stomach and oesophagus. Treatment with PPIs is usually extended indefinitely for maintaining symptom control, putting the patient at risk of adverse effects. On the other hand, there is also a tendency for physicians to prescribe these drugs unnecessarily for minor dyspepsia. The use of these best-selling drugs is expected to increase further as they are now available over-the-counter in many countries . Several newer PPIs are now available on the market with claims of superior therapeutic efficacy which are also excessively prescribed without considering their cost-effectiveness. This article examines why PPIs are now the leading antisecretory drugs, clinical aspects to be considered when prescribing newer PPIs, indications and recommended duration of treatment in each situation, over-prescription of PPIs, and adverse reactions that can emerge with long-term use.

Entities:  

Keywords:  Gastro-oesophageal reflux/drug therapy; Peptic ulcer/drug therapy; Physician’s practice patterns/economics; Proton pump inhibitors; Proton pump inhibitors/adverse effects

Year:  2011        PMID: 26190705     DOI: 10.1007/s12328-011-0208-y

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  94 in total

Review 1.  Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

Authors:  C A Stedman; M L Barclay
Journal:  Aliment Pharmacol Ther       Date:  2000-08       Impact factor: 8.171

2.  Chronic proton pump inhibitor therapy and the risk of colorectal cancer.

Authors:  Yu-Xiao Yang; Sean Hennessy; Kathleen Propert; Wei-Ting Hwang; Alireza Sedarat; James D Lewis
Journal:  Gastroenterology       Date:  2007-06-20       Impact factor: 22.682

3.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 4.  Effects of proton pump inhibitors on gastric emptying: a systematic review.

Authors:  Masaki Sanaka; Takatsugu Yamamoto; Yasushi Kuyama
Journal:  Dig Dis Sci       Date:  2009-12-10       Impact factor: 3.199

5.  Concordance between use of proton pump inhibitors and prescribing guidelines.

Authors:  P I Pillans; P A Kubler; J M Radford; V Overland
Journal:  Med J Aust       Date:  2000-01-03       Impact factor: 7.738

6.  On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial.

Authors:  T Lind; T Havelund; L Lundell; H Glise; K Lauritsen; S A Pedersen; O Anker-Hansen; A Stubberöd; G Eriksson; R Carlsson; O Junghard
Journal:  Aliment Pharmacol Ther       Date:  1999-07       Impact factor: 8.171

7.  Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.

Authors:  S J Sontag; D G Kogut; R Fleischmann; D R Campbell; J Richter; M Robinson; M McFarland; S Sabesin; G A Lehman; D Castell
Journal:  Am J Gastroenterol       Date:  1997-03       Impact factor: 10.864

Review 8.  Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.

Authors:  A B Thomson
Journal:  Curr Gastroenterol Rep       Date:  2000-12

9.  Influence of proton pump inhibitor use in gastrointestinal polyps.

Authors:  Wen-Hung Hsu; I-Chen Wu; Chao-Hung Kuo; Yu-Chung Su; Chien-Yu Lu; Fu-Chen Kuo; Chang-Ming Jan; Wen-Ming Wang; Deng-Chyang Wu; Fang-Jung Yu
Journal:  Kaohsiung J Med Sci       Date:  2010-02       Impact factor: 2.744

10.  Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials.

Authors:  Maribel Salas; Alexandra Ward; Jaime Caro
Journal:  BMC Gastroenterol       Date:  2002-07-15       Impact factor: 3.067

View more
  4 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  Survey-Based Analysis of Current Trends for Prescribing Gastrointestinal Protectants among Small-Animal General Practitioners in Portugal.

Authors:  Rita Baptista; Ryane Englar; Berta São Braz; Rodolfo Oliveira Leal
Journal:  Vet Sci       Date:  2021-04-23

3.  Educational Intervention Improves Proton Pump Inhibitor Stewardship in Outpatient Gastroenterology Clinics.

Authors:  Megan J Walker; Nicholas R Crews; Mustapha El-Halabi; Nabil F Fayad
Journal:  Gastroenterology Res       Date:  2019-11-21

4.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.